Clinical trial NCT05867849
Status: RecruitingPhase 3Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Cannabidiol for Bipolar Depression (CBD-BD)
- Record number
- NCT05867849
- Status
- Recruiting
- Type and phase
- Clinical trial, phase 3
- Participants
- Target: 360
- Condition (as registered)
- Bipolar Disorder
- Countries
- Canada
- Topic in the guide
- Bipolar Depression
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: October 15, 2023
- End of data collection for primary results: December 2029 (expected)
- Trial completion: December 2030 (expected)
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Bipolar Depression: ongoing trials · Thinking of taking part? Which specialist to see